Study details
Enrolling now
A Study of [14C]-LY4064809 in Healthy Participants
Eli Lilly and Company
NCT IDNCT07519525ClinicalTrials.gov data as of Apr 2026
Phase
Phase 1
Ages
18–55
Locations
1 site in WI
What this study is about
This Phase 1 study is focused on people with healthy volunteers.
Simplified from trial records by PatientMatch.
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Standard assignment
Assignment is predetermined by the study protocol.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endpoints
Secondary: PK of Total Radioactivity: Plasma Area Under the Concentration Versus Time Curve (AUC) of [14C]-LY4064809, Pharmacokinetics (PK): Plasma Maximum Concentration (Cmax) of LY4064809